Abstract
Molecular docking calculations combined with chemically focused libraries can bring insight in the exploration of the structure–activity relationships for a series of related compounds against an RNA target. Yet, the in silico engine must be fueled by experimental observations to drive the research into a more effective ligand-discovery path. Here we show how molecular docking predictions can be coupled with in-line probing assays to explore the available chemical and configurational space in a riboswitch binding pocket.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Guha R (2013) On exploring structure-activity relationships. Methods Mol Biol 993:81–94. doi: 10.1007/978-1-62703-342-8_6
Bleicher KH, Bohm HJ, Muller K, Alanine AI (2003) Hit and lead generation: beyond high-throughput screening. Nat Rev Drug Discov 2:369–378
Jorgensen WL (2004) The many roles of computation in drug discovery. Science 303:1813–1818
Shoichet BK (2004) Virtual screening of chemical libraries. Nature 432:862–865
Orry AJ, Abagyan RA, Cavasotto CN (2006) Structure-based development of target-specific compound libraries. Drug Discov Today 11:261–266
Leach AR, Hann MM (2000) The in silico world of virtual libraries. Drug Discov Today 5:326–336
Valler MJ, Green D (2000) Diversity screening versus focussed screening in drug discovery. Drug Discov Today 5:286–293
Villar HO, Koehler RT (2000) Comments on the design of chemical libraries for screening. Mol Divers 5:13–24
Mulhbacher J, Brouillette E, Allard M, Fortier LC, Malouin F, Lafontaine DA (2010) Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways. PLoS Pathog 6:e1000865
Irwin JJ, Shoichet BK (2005) ZINC – a free database of commercially available compounds for virtual screening. J Chem Inf Model 45:177–182
Irwin JJ, Sterling T, Mysinger MM, Bolstad ES Coleman RG (2012) ZINC: a free tool to discover chemistry for biology. J Chem Inf Model (Epub ahead of print)
Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267:727–748
Verdonk ML, Cole JC, Hartshorn MJ, Murray CW, Taylor RD (2003) Improved protein-ligand docking using GOLD. Proteins 52:609–23
Li Y, Shen J, Sun X, Li W, Liu G, Tang Y (2010) Accuracy assessment of protein-based docking programs against RNA targets. J Chem Inf Model 50:1134–1146
Batey RT, Gilbert SD, Montange RK (2004) Structure of a natural guanine-responsive riboswitch complexed with the metabolite hypoxanthine. Nature 432:411–415
Irwin JJ, Shoichet BK, Mysinger MM, Huang N, Colizzi F, Wassam P, Cao Y (2009) Automated docking screens: a feasibility study. J Med Chem 52:5712–5720
Mysinger MM, Carchia M, Irwin JJ, Shoichet BK (2012) Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem 55:6582–6594
Serganov A, Yuan YR, Pikovskaya O, Polonskaia A, Malinina L, Phan AT, Hobartner C, Micura R, Breaker RR, Patel DJ (2004) Structural basis for discriminative regulation of gene expression by adenine- and guanine-sensing mRNAs. Chem Biol 11:1729–1741
Mandal M, Boese B, Barrick JE, Winkler WC, Breaker RR (2003) Riboswitches control fundamental biochemical pathways in Bacillus subtilis and other bacteria. Cell 113:577–586
Bissantz C, Kuhn B, Stahl M (2010) A medicinal chemist’s guide to molecular interactions. J Med Chem 53:5061–5084
Muller K, Faeh C, Diederich F (2007) Fluorine in pharmaceuticals: looking beyond intuition. Science 317:1881–1886
Voth AR, Khuu P, Oishi K, Ho PS (2009) Halogen bonds as orthogonal molecular interactions to hydrogen bonds. Nat Chem 1:74–79
Gilbert SD, Reyes FE, Edwards AL, Batey RT (2009) Adaptive ligand binding by the purine riboswitch in the recognition of guanine and adenine analogs. Structure 17:857–868
Mandal M, Breaker RR (2004) Adenine riboswitches and gene activation by disruption of a transcription terminator. Nat Struct Mol Biol 11:29–35
Irwin JJ, Raushel FM, Shoichet BK (2005) Virtual screening against metalloenzymes for inhibitors and substrates. Biochemistry 44:12316–12328
Milletti F, Vulpetti A (2010) Tautomer preference in PDB complexes and its impact on structure-based drug discovery. J Chem Inf Model 50:1062–1074
Martin YC (2009) Let’s not forget tautomers. J Comput Aided Mol Des 23:693–704
Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14(33–8):27–28
Bohm HJ, Banner D, Bendels S, Kansy M, Kuhn B, Muller K, Obst-Sander U, Stahl M (2004) Fluorine in medicinal chemistry. Chembiochem 5:637–643
Wuitschik G, Carreira EM, Wagner B, Fischer H, Parrilla I, Schuler F, Rogers-Evans M, Muller K (2010) Oxetanes in drug discovery: structural and synthetic insights. J Med Chem 53:3227–3246
Acknowledgements
This work was supported by the National Sciences and Engineering Research Council of Canada (NSERC). D.A.L. is a Canadian Institutes of Health Research (CIHR) New Investigator Scholar. F.C. was supported by the “Young SISSA Scientist” grant (FISB.647 2011) for independent research development. F.C. and G.B. acknowledge the European Research Council for funding through the Starting Grant S-RNA-S (no. 306662).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Colizzi, F., Lamontagne, AM., Lafontaine, D.A., Bussi, G. (2014). Probing Riboswitch Binding Sites with Molecular Docking, Focused Libraries, and In-line Probing Assays. In: Lafontaine, D., Dubé, A. (eds) Therapeutic Applications of Ribozymes and Riboswitches. Methods in Molecular Biology, vol 1103. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-730-3_11
Download citation
DOI: https://doi.org/10.1007/978-1-62703-730-3_11
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-729-7
Online ISBN: 978-1-62703-730-3
eBook Packages: Springer Protocols